How Serum Biomarkers can Guide aGHVD Therapy: Results not matching up with GVHD, TMA (Thrombotic Microangiopathy) and COD.
Drs. James Ferrara, Icahn School of Medicine at Mount Sinai gives this presentation, originally at the Tandem Meetings of ASBMT and CIBMTR 2022.
(IV of IV)
Copyright © 2024 Eurofins Viracor, LLC. All Rights Reserved.
